Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CAVA GROUP, INC. | Director | Common Stock | 9.51M | $1.42B | $149.40 | Dec 5, 2024 | Direct |
LEXICON PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 136M | Dec 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CAVA | CAVA GROUP, INC. | Dec 5, 2024 | 0 | $0 | 3 | Dec 16, 2024 | Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Dec 5, 2024 | 0 | $0 | 3 | Dec 16, 2024 | Director, 10%+ Owner |